Pure Global AI
Disease / condition

Pancreatic Cancer clinical trials

Free access to 874 studies10+ countriesUpdated daily135 recruiting
VerifiedClinicalTrials.gov · WHO ICTRP · regional registries
874
Total trials
10+
Countries
10+
Sponsors
135
Recruiting
By phase
Phase 2297
N/A263
Phase 1122
Early Phase 189
Phase 364
By status
Completed392
Recruiting135
Unknown104
Terminated98
Not yet recruit...74
Top countries
United States of America387
China120
South Korea35
Japan28
Italy23
Top sponsors
Sidney Kimmel Comp...27
M.D. Anderson Canc...20
H. Lee Moffitt Can...15
Alliance for Clini...14
Memorial Sloan Ket...14
Recent trials
Latest clinical trials for Pancreatic Cancer
Nimotuzumab Combined With GX as Postoperative Adjuvant Therapy in Pancreatic Cancer
Tianjin Medical University Can... · China
NCT06409429Not yet recr...
Phase
Phase 2/3
Evaluating Nimotuzumab in Combination With AG Regimen for Pancreatic Cancer With Liver Metastases : A Prospective, Single-Arm, Phase II Study
Tianjin Medical University Can... · China
NCT06404840Recruiting
Phase
Phase 2
Nimotuzumab Plus AG in Pancreatic Cancer With Liver Metastasis
Tianjin Medical University Can... · China
NCT06405685Recruiting
Phase
Phase 2
Risk Factors of Postoperative Complications and Survival Rate in Pancreatic Ductal Adenocarcinoma Patients
Jinling Hospital, China · China
NCT06378853Completed
The Prognostic Impact of Surufatinib for the Treatment of Advanced Pancreatic Ductal Adenocarcinoma
Luo Cong · China
NCT06378580Completed
Treatment of Irinotecan Hydrochloride Liposome Injection II in China: a Real World Study of Pancreatic Cancer Patients
Peking Union Medical College H... · China
NCT06375473Not yet recr...
Newly Emerging Immunotherapy for Pancreatic Cancer Treatment
Fudan University · China
NCT06370754Not yet recr...
Phase
Phase 1/2
Single-arm Study of Nimotuzumab Combined With mFOLFIRNIOX as Postoperative Adjuvant Therapy in Pancreatic Cancer
The Affiliated Nanjing Drum To... · China
NCT06389760Recruiting
Phase
Phase 2
PD-1 Combined With Chemotherapy and PULSAR in LAPC and Local Recurrence Patients
Fudan University · China
NCT06359275Recruiting
Phase
Phase 2
Oncolytic Virus Plus Anti-PD1 and Chemotherapy as Preoperative Therapy for Patients With BRPC/LAPC
Sichuan University · China
NCT06346808Not yet recr...
Phase
Phase 1
XH001 Combination With Ipilimumab and Chemotherapy for Patients With Resected Pancreatic Cancer
Wu Wenming · China
NCT06353646Not yet recr...
Epigenomic and Machine Learning Models to Predict Pancreatic Cancer
European Institute of Oncology · France,Italy,Romania,Spain
NCT06334458Recruitment ...
Cancer Coaching and Remote Education for Self-Empowerment (CARES) Study
H. Lee Moffitt Cancer Center a... · United States of America
NCT06323291Recruiting
Phase
Phase 1
First-line Regimen With QL1706 Plus Chemo ± Bev in PDAC Patients
Fudan University
NCT06313970Not yet recr...
Phase
Phase 2
Study of Neoantigen mRNA Vaccines in Patients With Resectable Pancreatic Cancer
Jinling Hospital, China · China
NCT06326736Recruiting
Phase
Phase 1
A Clinical Study of AL2846 Capsule Combined With Gemzar Injection in the Treatment of Advanced Pancreatic Cancer
Chia Tai Tianqing Pharmaceutic... · China
NCT06278493Completed
Phase
Phase 1/2
Clinical Study of Multi-mode Thermal Ablation for the Treatment of Pancreatic Cancer With Liver Metastasis
Shanghai General Hospital, Sha... · China
NCT06307080Recruiting
A CT-based Radiomics Model to Predict Survival-graded Fibrosis in PDAC
First Affiliated Hospital, Sun... · China
NCT06267690Completed
Stereotactic Body Radiation Therapy Followed by NALIRIFOX vs NALIRIFOX for Borderline Resectable Pancreatic Cancer
Tianjin Medical University Can...
NCT06259058Not yet recr...
Phase
Phase 1/2
Comparing Astragalus Plus Gemcitabine to Gemcitabine Alone as Neoadjuvant Treatment for Pancreatic Cancer Patients
Shenzhen University General Ho... · China
NCT06234072Not yet recr...
Phase
Phase 2
About this profile

Access comprehensive clinical trial information for Pancreatic Cancer through Pure Global AI's free database. This collection includes 874 clinical trials across multiple phases including Phase 2, N/A, Phase 1. Currently, 135 trials are actively recruiting participants.

Research for Pancreatic Cancer is being conducted in United States of America, China, South Korea and 7+ other countries. Leading sponsors include Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins and M.D. Anderson Cancer Center. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Pure Global AI provides free access to 874 clinical trials studying Pancreatic Cancer, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.

Top research sponsors include Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, M.D. Anderson Cancer Center, H. Lee Moffitt Cancer Center and Research Institute, among others.